Maximizing the effect of an α7 nicotinic receptor PAM in a mouse model of schizophrenia-like sensory inhibition deficits.
about
Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disordersRecurrent copy number variations as risk factors for neurodevelopmental disorders: critical overview and analysis of clinical implications.Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors.
P2860
Maximizing the effect of an α7 nicotinic receptor PAM in a mouse model of schizophrenia-like sensory inhibition deficits.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Maximizing the effect of an α7 ...... e sensory inhibition deficits.
@ast
Maximizing the effect of an α7 ...... e sensory inhibition deficits.
@en
type
label
Maximizing the effect of an α7 ...... e sensory inhibition deficits.
@ast
Maximizing the effect of an α7 ...... e sensory inhibition deficits.
@en
prefLabel
Maximizing the effect of an α7 ...... e sensory inhibition deficits.
@ast
Maximizing the effect of an α7 ...... e sensory inhibition deficits.
@en
P2093
P2860
P1433
P1476
Maximizing the effect of an α7 ...... e sensory inhibition deficits.
@en
P2093
Karen E Stevens
Kirsten L Floyd
Lijun Zheng
P2860
P356
10.1016/J.BRAINRES.2015.02.044
P407
P577
2015-03-02T00:00:00Z